Introduction
CERVICAL CANCER
The disruptions in the US healthcare system due to the COVID-19 pandemic have resulted in a sharp decline in routine primary care, including cervical cancer screening (Safety net health systems, which provide care regardless of the patient’s ability to pay, provide care for a large proportion of the medically underserved population in the US and have become increasingly important during the COVID-19 pandemic (Barriers to cervical cancer screening among safety net system patients, both pre- and post–pandemic, have not been fully described, and thus research to inform targeted approaches to increase screening participation is needed. A previous study found that under-screened women within a safety net system were more likely to have limited knowledge of HPV and report cost, time, and lack of childcare as barriers to Pap screening compared to screened women (Self-sample HPV testing is effective at detecting high-risk HPV (Here, we describe perceived barriers to cervical cancer screening and motivators to use an at-home self-sampling kit for HPV testing among women in an urban safety net health system. The survey was conducted among a subset of participants from the PRESTIS trial, a pragmatic trial assessing the effectiveness of mailed self-sample HPV kits to improve cervical cancer screening among women in a safety net healthcare system (